You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
COVID-19 Resource Center


Getinge Group Q4 Report 2007

Getinge Group Q4 Report 2007

Reporting period January – December

• Orders received increased by 24.1% to SEK 16,519 million (13,316)
• Net sales increased by 26.5% to SEK 16,445 million (13,001)
• Profit before tax amounted to SEK 1,775 million (1,728)
• Net profit amounted to SEK 1,261 million (1,259)
• Earnings per share amounted to SEK 6.24 (6.21)
• Dividend per share proposed at SEK 2.40 (2.20)
• Acquisition of Boston Scientific’s cardio and vascular surgery divisions
• The Board of Getinge AB proposes a new share issue of approximately SEK 1,500 million for financing and continued expansion.
• New financial targets

Fourth quarter

• Orders received increased organically by 5.5%
• Net sales increased by 29.1% to SEK 5,157 million (3,995)
• Operating profit (EBITA) before restructuring increased by 29.2 % to SEK 1,096 million (848)